LINC01883

Across TCGA pan-cancer cohorts, LINC01883 RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated LINC01883 data layer.

The strongest signal is observed in cholangiocarcinoma (CHOL), where higher LINC01883 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01883 expression acts as an unfavorable survival marker, although some lineages such as LIHC and KIRP show a favorable association.

CHOL, UCEC, and BLCA are the cancer types where LINC01883 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CHOL	OS	Tertile	All	0.110	0.746	<.001	63	view →
UCEC	OS	Tertile	All	0.776	0.886	.002	54	view →
BLCA	OS	Tertile	IV	0.199	0.596	.006	39	view →
LIHC	DFS	Tertile	III,IV	0.544	0.107	.005	21	view →
KIRP	DFS	Tertile	III,IV	1.000	0.253	.020	18	view →
MESO	OS	Tertile	IV	0.077	0.592	.019	18	view →
GBM	DFS	Tertile	All	0.108	0.295	.045	9	view →
ESCA	DFS	Median	All	1.000	0.533	.012	9	view →
LGG	DFS	Tertile	All	0.720	0.839	.017	9	view →
BRCA	DFS	Quartile	All	0.633	0.489	.028	4	view →
OV	OS	Quartile	All	0.794	0.853	.043	2	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

LINC01883–CHOL (OS)

Open the CHOL breakdown →